Flexray Medical ApS: Financial statements 2023
CVR: 36890509
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
Flexray Medical ApS (CVR 36890509) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 4,274,536 and a net result of DKK 859,959 compared with DKK 2,416,705 the year before. That is a decrease of 22% compared with the year before. Equity in the 2023 report amounted to DKK 7,225,903. The solvency ratio was 57%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 4,274,536
- Profit/Loss
- DKK 859,959
- Equity
- DKK 7,225,903
- Total Assets
- DKK 12,677,293
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 4.3 mio. | 860 t. | 7.2 mio. | 4 |
| 2022 | - | 5.5 mio. | 2.4 mio. | 6.8 mio. | 3 |
| 2021 | - | 5.5 mio. | 2.7 mio. | 5.1 mio. | 3 |
| 2020 | - | 1.6 mio. | 78 t. | 3.9 mio. | 3 |
| 2019 | - | 3.9 mio. | 1.6 mio. | 4.2 mio. | 3 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Flexray Medical ApS
Flexray Medical ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2015. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Mads Vittrup and Simon Dyrup Nielsen. The company is owned by Simba Holding ApS and SDHD Holding ApS. The company has 5 employees (2026). In 2026, the company reported a gross profit of DKK 2,930,775 and a net result of DKK 733,340 compared with DKK 2,437,076 the year before. Equity in the 2026 report amounted to DKK 10,144,844.